PFAS testing requirements have tightened considerably in recent years, and it’s no longer just the water industry that needs to pay attention. Manufacturers, waste handlers, food producers and their supply chain partners are increasingly being asked to show what’s present in their water, effluent and materials, often at concentrations that were rarely measured a decade ago.
For many organisations, the first sign of this change isn’t new legislation landing on someone’s desk. It’s a question during a permit renewal. A new condition in a customer agreement. Or a questionnaire asking for data you’ve never had to provide before.
Getting ahead of PFAS testing means having four things clear:
- Understand whether you need screening or targeted analysis, as the two involve very different levels of testing.
- Decide whether outsourcing or in-house testing makes commercial sense for your sample volumes and turnaround requirements.
- Put the right sampling, documentation and audit processes in place so your results can stand up to scrutiny.
The important part is not to overcomplicate things. Start with the actual requirement, then build the testing programme around it.
Understanding What the Regulations Actually Ask For
PFAS testing requirements broadly fall into two categories, and getting this distinction right can save a lot of unnecessary expense.
Some requirements ask for a screening figure covering total or adsorbable organic fluorine. In simple terms, this helps establish whether fluorinated substances are present at all. Others require individual named compounds to be measured and reported at specified detection limits. That difference matters. Screening obligations are far cheaper to satisfy, so don’t commission detailed testing until you know which type of result is actually required.
Standards referenced in permits and contracts include EPA Method 1621, DIN 38409-59 and ISO/DIS 18127 for screening approaches, alongside DIN 38407-53 for targeted determinations. Each specifies the analytical technique considered acceptable, and several use combustion followed by ion chromatography.
Deciding Between an External Lab and In-House Capability
For organisations testing only occasionally, perhaps a handful of samples each quarter, outsourcing is often the straightforward choice.
Costs remain variable, there’s no capital investment, and responsibility for accreditation sits with the external laboratory. The calculation starts to change as sample numbers increase. Turnaround time can become a real constraint, particularly when you need a result before a batch can ship or a discharge can continue. And repeat testing after a failed result can push annual sample volumes higher than expected.
Work out your likely annual sample count honestly, including those repeat tests. Then compare the total outsourcing cost with instrument and consumable costs over a five-year period. Many operations find that the crossover point arrives sooner than they initially expected once routine monitoring begins.
If you bring analysis in-house, the key is to match the system to the work you actually need to do. Your analytes, sample matrix, required detection limits, expected throughput and applicable standards should all shape the specification. Suppliers such as Metrohm offer ion chromatography systems ranging from compact instruments for routine determinations to modular platforms that can accommodate automation and additional detectors as requirements grow.
Before committing, ask prospective suppliers to demonstrate the system using your own samples. And check that local service engineers and application support are genuinely available in your region. That support matters a lot more when an instrument is part of a routine compliance workflow.
Screening Versus Targeted Analysis
Screening by adsorbable organic fluorine works well as a first pass across multiple sample points. Organofluorines are adsorbed onto activated carbon and combusted at high temperature, converting bound fluorine into hydrogen fluoride. The resulting fluoride is then quantified.
For a site with several discharge points, storage areas or process streams, this creates a practical way to narrow the problem down. Screen everything first, then invest in more detailed work where the initial results show something meaningful.
Targeted analysis is different. It becomes necessary when a specific substance has to be reported against a numerical limit. Short-chain and ultrashort-chain compounds are particularly challenging because they’re highly water soluble, mobile and poorly captured by older methods. Trifluoroacetic acid is a common example. Quantifying it reliably requires chromatographic separation coupled with tandem mass spectrometry.
In practice, a phased approach makes sense: screen broadly, identify the problem areas and then commission targeted work with a clear question in mind. There’s little value in testing every sample at maximum sensitivity when the requirement doesn’t call for it.
Sample Handling and Preparation
You can have an excellent analytical method and still end up with poor results if sample handling isn’t right.
Particulates can block flow paths, damage separation columns and create baseline noise that compromises quantification. Filtration through 0.45 or 0.2 micrometre membranes is standard practice, with dilution or extraction used where sample matrices are more complex.
Contamination control also needs particular attention with fluorinated compounds. Certain plastics and laboratory consumables can introduce the very substances you’re trying to measure. That makes a written sampling protocol essential. And it shouldn’t live only in the laboratory. Everyone who collects samples needs to understand and follow it.
Once sample volumes increase, automated inline preparation can also be worth considering. Handling filtration, dilution and calibration within the instrument reduces manual handling errors, protects expensive consumables and frees technicians to focus on other work.
Over time, those benefits can translate into longer column life and fewer repeated runs.
Documentation, Audit Trails and Defensible Results
A result is only useful if you can show where it came from. Regulators, customers and insurers may want to know who performed the analysis, when it was carried out, which method was used and whether the data was edited afterwards.
Instrument software should therefore record user actions, method changes and data modifications automatically. Version control and mandatory comments for edits provide an audit trail rather than leaving you trying to reconstruct what happened months later.
Systems meeting 21 CFR Part 11 requirements handle this as standard, and comparable expectations apply under UK and EU good laboratory practice.
Keep method validation records, calibration certificates, maintenance logs and evidence of staff competency alongside the analytical results themselves. And where ion chromatography forms part of your quality system, export results directly into your laboratory information management system rather than manually transcribing figures. Manual transcription creates another opportunity for errors and makes results harder to defend later.
Getting Your Testing Programme Ready
One of the easiest things to underestimate is time. Instrument delivery, installation qualification, method validation, staff training and proficiency testing can take six months or more from placing an order to producing the first reportable result. That means waiting until a testing obligation becomes urgent can leave you with very few options.
Start by reviewing your permits this quarter and confirming the exact wording of any PFAS testing requirement. Then arrange screening across the relevant sample points so you understand what you’re dealing with.
From there, speak with an application specialist about your matrices, sample volumes and required detection limits. That conversation should make it much clearer whether outsourcing or building in-house capability makes sense for your operation, before you commit significant time or money.
